Optimum Investment Advisors Novo Nordisk A S Transaction History

Optimum Investment Advisors

$216 Million
Q1 2024

A detailed history of Optimum Investment Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Optimum Investment Advisors holds 10,122 shares of NVO stock, worth $1.41 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

10,122

Previous 9,922 2.02%

Holding current value

$1.41 Million

Previous $1.03 Million 26.61%

% of portfolio

0.6%

Previous 0.52%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$102.11 - $135.92 $20,422 - $27,183	200 Added 2.02%	10,122 $1.3 Million
Q4 2023 Jan 08, 2024	SELL	$87.78 - $105.45 $48,279 - $57,997	-550 Reduced 5.25%	9,922 $1.03 Million
Q3 2023 Oct 13, 2023	BUY	$90.94 - $199.54 $454,700 - $997,700	5,000 Added 91.37%	10,472 $952,000
Q2 2023 Aug 03, 2023	BUY	$155.98 - $172.65 $226,170 - $250,342	1,450 Added 36.05%	5,472 $885,000
Q4 2022 Jan 05, 2023	BUY	$102.55 - $135.33 $10,255 - $13,533	100 Added 2.55%	4,022 $0

Q3 2022 Oct 24, 2022	BUY	$95.28 - $116.93 $2,096 - $2,572	22 Added 0.56%	3,922 $391,000
Q2 2022 Jul 12, 2022	SELL	$103.24 - $121.81 $25,810 - $30,452	-250 Reduced 6.02%	3,900 $435,000
Q4 2021 Mar 17, 2022	SELL	$95.88 - $117.08 $4,794 - $5,854	-50 Reduced 1.19%	4,150 $465,000
Q2 2021 Aug 02, 2021	SELL	$67.66 - $84.76 $20,298 - $25,428	-300 Reduced 6.67%	4,200 $352,000
Q4 2019 Jan 22, 2020	BUY	$49.86 - $58.26 $19,944 - $23,304	400 Added 9.76%	4,500 $260,000
Q3 2019 Oct 17, 2019	BUY	$47.54 - $53.43 $19,016 - $21,372	400 Added 10.81%	4,100 $212,000
Q1 2019 May 03, 2019	BUY	$46.36 - $52.63 $171,532 - $194,731	3,700 New	3,700 $194,000
Q2 2018 Oct 05, 2018	SELL	$44.29 - $50.42 $57,577 - $65,546	-1,300 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$48.49 - $58.14 $63,037 - $75,582	1,300 New	1,300 $64,000

Others Institutions Holding NVO

# of Institutions

1,859

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $313B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.

Account

Optimum Investment Advisors Novo Nordisk A S Transaction History